HMMR Antikörper (AA 1-250)
Kurzübersicht für HMMR Antikörper (AA 1-250) (ABIN7858770)
Target
Alle HMMR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-250
-
Verwendungszweck
- CD168 / RHAMM Antibody
-
Spezifität
- Hyaluronic acid (HA) is a nonsulfated glycosaminoglycan that regulates cell adhesion and migration. HA effects are mediated through two receptors, CD44 (also designated HCAM) and the receptor of hyaluronic acid mediated motility (RHAMM). RHAMM, also designated intracellular hyaluronic acid binding protein (IHABP) and CD168, is a matrix receptor, which is linked to the plasma membrane by a GPI anchor and regulates cell motility. RHAMM expression is upregulated in malignant lymphoid tissues and is subsequently implicated in tumor progression and metastasis formation, as well as signal transduction. Although still unclear, RHAMM is thought to exist as several isoforms ranging in size. A variant isoform, designated v4, is a protein that when over-expressed, is thought to be the cause of transformation and metastasis formation in fibroblasts.
-
Aufreinigung
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- Recombinant fragment (around aa1-250) of human HMMR protein (exact sequence is proprietary)
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
-
- HMMR (Hyaluronan-Mediated Motility Receptor (RHAMM) (HMMR))
-
Andere Bezeichnung
- CD168
-
Hintergrund
-
CD168, CD168 antigen, HMMR, Hyaluronan-mediated motility receptor (RHAMM), IHABP, Intracellular hyaluronic acid-binding protein, Receptor for hyaluronan-mediated motility
breast cancer or placenta.|Human breast
-
Molekulargewicht
- 85-90kDa
-
Gen-ID
- 3161, 728200
-
UniProt
- O75330
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-